| |
|
|
|
Catabasis Pharmaceuticals Inc.  
|
|
0.844 0.006 (0.01%) |
09-21 16:00 |
|
Open: |
0.83 |
Pre close: |
0.8379 |
Target:
|
1.00
|
|
High: |
0.844 |
Low: |
0.79 |
Resistance:
|
0.86
1.00
|
|
Volume: |
1,127,559 |
Market Cap: |
60M |
Support:
|
0.70
0.61
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.80
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
0.76 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
1.03  |
Stochastic Oscillator |
%K(14,3):
|
87.53 |
|
MA(250): |
1.50 |
%D(3): |
75.65 |
|
Average Volume(K) |
3-Month: |
97984
|
52-Week |
High:
|
3.78 |
|
10-Days: |
113679 |
Low: |
0.61 |
|
RSI |
RSI(14):
|
62.46 |
Change(%): |
-53.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.040 |
Return on Equity (ttm) |
-78.5 |
Shares Out. (M) |
71.04 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-64.7 |
Shares Float (M) |
70.53 |
|
EPS Est. Next Year |
-1.100 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.330 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
32.40 |
|
Forward EPS |
-1.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
158 |
|
Book Value (p.s.) |
1.270 |
EBITDA (p.s.) |
-0.096 |
P/E |
-0.81 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.66 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-25.47 |
P/S |
2997888000.00 |
|
Operating Margin |
-5157.80 |
Levered Free Cash Flow
(M) |
-14.70 |
P/CF |
-2.35 |
|
|
|
|
|
|
